For healthcare epidemiologists, infection preventionists, and other medical professionals responding to COVID-19.

Time-sensitive news/events/alerts not included below.

SHEA COVID-19 Response

• Novel Coronavirus 2019 (COVID-19) FAQ
• MySHEA https://bit.ly/2Uv5kiR (SHEA members only discussion including shared resources; login required) 
• SHEA LearningCE COVID-19 and Rapid Response
• Facebook Live - SHEA Board of Trustees

SHEA Press Statements

• Joint Statement President Trump Must Invoke Defense Production Act Now for Medical Supply and Equipment Production
• SHEA Press Statement on Defense Production Act
• SHEA Novel Coronavirus Statement

Infection Prevention and Control

• CDC Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Healthcare Settings 
• CDC Infection Prevention and Control FAQ
• CDC Healthcare Professionals: FAQs
• CDC Caring for Patients with Confirmed or Possible COVID-19 
• WHO COVID-19 technical guidance: Infection prevention and control 

Hand Hygiene

• CDC Hand Hygiene FAQs for Healthcare Personnel Responding to COVID-2019 
• FDA Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products during COVID-19
• FDA Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products during COVID-19 

PPE

• N95 Filtering Facepiece Respirator Ultraviolet Germicidal Irradiation (UVGI) Process for Decontamination and Reuse (University of Nebraska)
• CDC PPE Recommendations
• CDC Strategies for Optimizing the Supply of PPE 

Occupational Health

• CDC Criteria for Return to Work for Healthcare Personnel with Confirmed or Suspected COVID-19
• CDC Risk Assessment and Management of HCP with Potential Exposure to COVID-19

Clinical Care and Treatment

• CDC Management of Patients with Confirmed COVID-19
• FDA Policy for Modifications to FDA-Cleared Ventilators, Accessories, and Other Respiratory Devices – Emergency Guidance for Industry and FDA 
• CDC Discontinuation of Precautions of Patients with COVID-19
• CDC Therapeutic Options for COVID-19 Patients

Special Settings and Populations

• CDC Presentation, Prevention, Treatment in Children
• CDC PUIs in Residential Settings 
• CDC Pregnant Women
• CDC Discontinuation of In-Home Isolation for Immunocompromised Persons 
• CDC Preparing for COVID-19: Long-term Care Facilities, Nursing Homes 
• CMS Information for Programs of All-Inclusive Care of the Elderly PACE Organizations (POs) Regarding Infection Control and Prevention of COVID-19 
• AMDA Guidance on COVID-19 in PALTC Settings Guidance

Testing and Cases

Testing

• CDC Public Health Testing Map
• CDC FAQs for Diagnostic Tools
• FDA Policy for Diagnostic Tests for COVID-19 

• CDC Cases Map 
• Johns Hopkins COVID-19 Dashboard
• European Centre for Diseases Prevention and Control Geographic Distribution and Histograms 

Quality Reporting and Reimbursement Policy

• CMS Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19 

Incident Management

• SHEA/CDC Outbreak Response Training Program (ORTP):
  • Outbreak Response and Incident Management: SHEA Guidance and Resources for Healthcare Epidemiologists in United States Acute-Care Hospitals 
  • Horizontal Strategies, Emerging Pathogens, Communications Toolkits for Outbreak Response
  • Effective Communication During a Crisis Webinars
• ASPR Emergency declarations and waivers 
• ASPR Healthcare planning checklist
• Alternate Care Site (ACS) Toolkit  - Federal Healthcare Resilience Task Force

US Agencies’ Healthcare Response Landing Pages

• CDC  - Official US guidance and recommendations for healthcare personnel responding to COVID-19
• WHO - International recommendations for healthcare personnel responding to COVID-19
• FDA - Diagnostics and vaccine research for developers and labs; PPE Emergency Use Authorization (EUA); guidance for industry, FDA staff; fraudulent products
• NIH - Clinical trials, information for labs, diagnostics FAQ, biosafety
• CMS - Waivers, billing and coding, coverage, facilities and labs, PACE organizations, CHIP
• ASPR - Incident management, ASPR TRACIE, Biomedical Advanced Research and Development Authority (BARDA)
• FEMA - Emergency circumstances, protective measures, rumor control, FAQs for public and communities
• HHS - Grants, contracts, laws, regulations

Trade Press

• ICHE COVID-19 Articles 
• Cambridge University Press Coronavirus Free Access Articles 
• CDC COVID-19 Publications 
• PubMed LitCovid 
• The Lancet Coronavirus Resource Centre 

Calls, Webinars, Events

• SHEA LearningCE COVID-19 and Rapid Response – Webinars and Resources 
• COCA Calls
• IDSA Podcast 

Newsletters

• CIDRAP 
• WHO Novel Coronavirus (2019-nCoV) Situation Reports  
• COCA Newsletter

Research Opportunities

• NIH Grants & Funding 
• Biomedical Advanced Research and Development Authority (BARDA) 

Affiliated Organizations

• APIC COVID-19 Resources (APIC)
• ASA COVID-19 Recommendations for Anesthesia Personnel
• ASM Novel Coronavirus (COVID-19) Resources
• ASPR Technical Resources, Assistance Center, and Information Exchange (TRACIE) 
• IDSA COVID-19 Resource Page  
• NETEC Resources 

For Consumers and Patients

• CDC COVID-19 and Underlying Conditions 
• FDA Fraudulent COVID-19 Consumer Test Kits 
• FDA Use of NSAIDs for COVID-19 
• Medline Patient Education